Come up with a name for your new list and we'll add to it:
Dicerna Pharmaceuticals raised a round of funding on , . Investors include
Oxford Bioscience Partners.
Dicerna Pharmaceuticals is a pharmaceutical company developing RNA interference (RNAi)-based therapeutics against genetically-defined targets in multiple disease areas, including cancer. Dicerna's the…